For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Podcast archive view
Vault Navigation
Podcast archive
Collection of podcasts created by New Zealand Doctor along with links to other podcasts of interest to our readers
Waiting for Covid by Lucy O'Hagan
System Fix: Episode 29 - New year, new minister
Waiting for COVID by Lucy O'Hagan
Waitng for COVID by Lucy O'Hagan

Educate Long Read - Fully-body vibration
Educate Long Read: Hand–arm vibration
System Fix: Episode 26 - Unwinding health reforms
Episode Seven: Eradicating hepatitis C in Aotearoa
Long Read: Episode 1 - Winners are Grinners; Lloyd McCann
New Zealand Doctor Rata Aotearoa journalist Alan Perrott's profiles Tāmaki Health chief executive Lloyd McCann in the first of our Long Read series

System Fix: Episode 24 - Chatting with Abbe Anderson